当前位置：
X-MOL 学术
›
medRxiv. Infect. Dis.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies: a nationwide cohort study in the OpenSAFELY platform
medRxiv - Infectious Diseases Pub Date : 2022-05-06 , DOI: 10.1101/2021.09.03.21262888 Brian MacKenna , Nicholas A. Kennedy , Amir Mehkar , Anna Rowan , James Galloway , Kathryn E Mansfield , Katie Bechman , Julian Matthewman , Mark Yates , Jeremy Brown , Anna Schultze , Sam Norton , Alex J Walker , Caroline E Morton , David Harrison , Krishnan Bhaskaran , Christopher T Rentsch , Elizabeth Williamson , Richard Croker , Seb Bacon , George Hickman , Tom Ward , Simon Davy , Amelia Green , Louis Fisher , William Hulme , Chris Bates , Helen J Curtis , John Tazare , Rosalind M Eggo , David Evans , Peter Inglesby , Jonathan Cockburn , Helen I McDonald , Laurie A Tomlinson , Rohini Mathur , Angel YS Wong , Harriet Forbes , John Parry , Frank Hester , Sam Harper , Ian J Douglas , Liam Smeeth , Charlie W Lees , Stephen JW Evans , Ben Goldacre , Catherine Smith , Sinead M Langan
medRxiv - Infectious Diseases Pub Date : 2022-05-06 , DOI: 10.1101/2021.09.03.21262888 Brian MacKenna , Nicholas A. Kennedy , Amir Mehkar , Anna Rowan , James Galloway , Kathryn E Mansfield , Katie Bechman , Julian Matthewman , Mark Yates , Jeremy Brown , Anna Schultze , Sam Norton , Alex J Walker , Caroline E Morton , David Harrison , Krishnan Bhaskaran , Christopher T Rentsch , Elizabeth Williamson , Richard Croker , Seb Bacon , George Hickman , Tom Ward , Simon Davy , Amelia Green , Louis Fisher , William Hulme , Chris Bates , Helen J Curtis , John Tazare , Rosalind M Eggo , David Evans , Peter Inglesby , Jonathan Cockburn , Helen I McDonald , Laurie A Tomlinson , Rohini Mathur , Angel YS Wong , Harriet Forbes , John Parry , Frank Hester , Sam Harper , Ian J Douglas , Liam Smeeth , Charlie W Lees , Stephen JW Evans , Ben Goldacre , Catherine Smith , Sinead M Langan
Background It is unclear if people with immune-mediated inflammatory diseases (IMIDs) (joint, bowel and skin) and on immune modifying therapy have increased risk of serious COVID-19 outcomes.
中文翻译：
与免疫介导的炎症性疾病和免疫调节疗法相关的严重 COVID-19 结果的风险：OpenSAFELY 平台中的一项全国性队列研究
背景目前尚不清楚患有免疫介导炎症性疾病 (IMID)（关节、肠道和皮肤）和接受免疫调节治疗的人是否会增加 COVID-19 严重后果的风险。
更新日期：2022-05-09
中文翻译：
与免疫介导的炎症性疾病和免疫调节疗法相关的严重 COVID-19 结果的风险：OpenSAFELY 平台中的一项全国性队列研究
背景目前尚不清楚患有免疫介导炎症性疾病 (IMID)（关节、肠道和皮肤）和接受免疫调节治疗的人是否会增加 COVID-19 严重后果的风险。
京公网安备 11010802027423号